We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Effect of Endurance Training in Patients With Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01584960
Recruitment Status : Completed
First Posted : April 25, 2012
Last Update Posted : December 2, 2013
Herlev Hospital
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark

April 24, 2012
April 25, 2012
December 2, 2013
April 2008
May 2012   (Final data collection date for primary outcome measure)
PSA doubling time [ Time Frame: 2 years ]
PSA dobling time [ Time Frame: 2 years ]
Complete list of historical versions of study NCT01584960 on ClinicalTrials.gov Archive Site
Insulin sensitivity, body composition and inflammation status [ Time Frame: 0 months, 6 months and 24 months of training ]
Same as current
Not Provided
Not Provided
The Effect of Endurance Training in Patients With Prostate Cancer
The Effect of Endurance Training on PSA Doubling Time, Body Composition, Insulin Sensitivity and Inflammation in Patients With Prostate Cancer
The aim of the present study is to investigate the effect of endurance on PSA doubling time in prostate cancer patients with an elevation in PSA following radical prostatectomy for localized cancer. Furthermore, underlying mechanisms such as reduction in inflammatory markers and improvement in insulin sensitivity and body composition are investigated.
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
  • Prostate Cancer
  • Insulin Sensitivity
  • Body Composition, Beneficial
Behavioral: endurance training
2 years of home-based endurance training
Experimental: Prostate cancer, endurance training
Prostate cancer patients doing 2 years of home-based endurance training Cross over design with a control group with no intervention
Intervention: Behavioral: endurance training
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
May 2012
May 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Prostate cancer patients with an increase in PSA following radical prostatectomy

Exclusion Criteria:

  • severe cardiovascular disease
  • severe arthritis
  • severe neuropathy
  • severe hypertension
  • therapy with antidiabetic agents
  • other treatment for prostate cancer than radical prostatectomy
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Inge Holm, Rigshospitalet, Denmark
Inge Holm
Herlev Hospital
Study Director: Bente K Pedersen Centre of Inflammation and Metabolism, Rigshospitalet
Rigshospitalet, Denmark
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP